Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 0.77 is 474% above its 5-year average of -0.21, near the high end of its 5-year range (-6.45–3.26).
890.35% above its 12-month average of 0.08.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 0.31.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T14:38:05.394Z. Historical observations retain their original dates. Historical series through 2026-10-05.
EARNINGS PER SHARE (EPS)
0.77
EARNINGS PER SHARE (EPS) AVG TTM
0.08
EARNINGS PER SHARE (EPS) AVG 3Y
-1.29
EARNINGS PER SHARE (EPS) AVG 5Y
-0.21
EARNINGS PER SHARE (EPS) AVG 10Y
-0.46
EARNINGS PER SHARE (EPS) AVG 15Y
-0.54
EARNINGS PER SHARE (EPS) AVG 20Y
-1.30
CURRENT VS TTM AVG
+890.35%
CURRENT VS 3Y AVG
+159.64%
CURRENT VS 5Y AVG
+474.24%
CURRENT VS 10Y AVG
+267.57%
CURRENT VS 15Y AVG
+243.27%
CURRENT VS 20Y AVG
+159.37%
Ironwood Pharmaceuticals, Inc.
Market Cap
$596.72M
Earnings Per Share (EPS)
0.77
TTM Avg
0.08
3Y Avg
-1.29
5Y Avg
-0.21
Market Cap
$605.22M
Earnings Per Share (EPS)
-2.82
TTM Avg
-1.69
3Y Avg
-1.06
5Y Avg
3.72
Market Cap
$580.22M
Earnings Per Share (EPS)
-1.68
TTM Avg
-1.67
3Y Avg
-1.05
5Y Avg
-1.14
Market Cap
$612.34M
Earnings Per Share (EPS)
-0.88
TTM Avg
-0.85
3Y Avg
-1.91
5Y Avg
-1.52
Market Cap
$624.17M
Earnings Per Share (EPS)
-0.83
TTM Avg
-1.21
3Y Avg
-1.36
5Y Avg
-1.94
Market Cap
$563.97M
Earnings Per Share (EPS)
-0.65
TTM Avg
-0.64
3Y Avg
-0.63
5Y Avg
-1.00
Market Cap
$562.50M
Earnings Per Share (EPS)
2.13
TTM Avg
0.97
3Y Avg
0.08
5Y Avg
-0.20
Market Cap
$560.00M
Earnings Per Share (EPS)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$569.15M
Earnings Per Share (EPS)
-3.68
TTM Avg
-3.44
3Y Avg
-2.54
5Y Avg
-10.12
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ironwood Pharmaceuticals, Inc. (IRWD) | $596.72M | 0.77 | 0.08 | -1.29 | -0.21 |
| Fulgent Genetics, Inc. (FLGT)vs › | $605.22M | -2.82 | -1.69 | -1.06 | 3.72 |
| OrthoPediatrics Corp. (KIDS)vs › | $580.22M | -1.68 | -1.67 | -1.05 | -1.14 |
| AngioDynamics, Inc. (ANGO)vs › | $612.34M | -0.88 | -0.85 | -1.91 | -1.52 |
| Climb Bio, Inc. (CLYM)vs › | $624.17M | -0.83 | -1.21 | -1.36 | -1.94 |
| Aquestive Therapeutics, Inc. (AQST)vs › | $563.97M | -0.65 | -0.64 | -0.63 | -1.00 |
| CorMedix Inc. (CRMD)vs › | $562.50M | 2.13 | 0.97 | 0.08 | -0.20 |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A | N/A | N/A | N/A |
| ArriVent BioPharma, Inc. (AVBP)vs › | $569.15M | -3.68 | -3.44 | -2.54 | -10.12 |
| Aura Biosciences, Inc. (AURA)vs › | $635.62M | -1.78 | -1.75 | -1.85 | -1.69 |
Trailing EPS (TTM)
$0.77
Forward EPS (Est.)
$1.22
P/E Ratio
4.7
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 0.15 |
| 2024-12-31 | 0.01 |
| 2023-12-31 | -6.45 |
| 2022-12-31 | 1.13 |
| 2021-12-31 | 3.26 |
| 2020-12-31 | 0.67 |
| 2019-12-31 | 0.38 |
| 2018-12-31 | -1.85 |
| 2017-12-31 | -0.79 |
| 2016-12-31 | -0.56 |
| 2015-12-31 | -1.00 |
| 2014-12-31 | -1.39 |
| 2013-12-31 | -2.35 |
| 2012-12-31 | -0.68 |
| 2011-12-31 | -0.65 |
| 2010-12-31 | -0.59 |
| 2009-12-31 | -10.00 |
| 2008-12-31 | -7.82 |
| 2007-12-31 | -7.41 |
| 2006-12-31 | -5.22 |
